Article metrics

Download PDFPDF

α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas

 

Online download statistics by month:

Online download statistics by month: December 2019 to July 2022

AbstractFullPdf
Dec 2019440
Jan 202028284
Feb 2020797913
Mar 202085854
Apr 20201131137
May 2020797916
Jun 2020727212
Jul 2020535310
Aug 2020707118
Sep 2020969639
Oct 202011511544
Nov 202010610839
Dec 202011811833
Jan 202112012065
Feb 202113113158
Mar 2021979742
Apr 2021989836
May 2021939356
Jun 202112112161
Jul 202111311350
Aug 202110010046
Sep 202112912961
Oct 202113013086
Nov 202110610665
Dec 2021878739
Jan 2022849747
Feb 2022697540
Mar 20228710449
Apr 2022687235
May 2022899458
Jun 2022979730
Jul 20228910227
Total292629871190